Etherna – Our Company
Since its inception, eTheRNA has raised a total amount of over EUR 58 million in equity investment, including a Series A financing of EUR 24 million announced in 2016 and Series B financing of EUR 34 million announced mid-2020.
Equity Investment Shareholders
Our Board of Directors
Who will bring eTheRNA’s mRNA-based TriMix technology to the next level.